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Abstract
Background
Rift Valley fever (RVF) is a mosquito-borne zoonotic disease characterized in South Africa
by large epidemics amongst ruminant livestock at very long, irregular intervals, mainly in the
central interior. However, the presence and patterns of occurrence of the virus in the eastern
parts of the country are poorly known. This study aimed to detect the presence of RVF virus
(RVFV) in cattle and goats in far northern KwaZulu-Natal province and to estimate the prev-
alence of antibodies to the virus and the incidence rate of seroconversion.
Methodology
Cross-sectional studies were performed in communally farmed cattle (n = 423) and goats
(n = 104), followed by longitudinal follow-up of seronegative livestock (n = 253) 14 times
over 24 months, representing 160.3 animal-years at risk. Exposure to RVFV was assessed
using an IgG sandwich ELISA and a serum neutralization test (SNT) and seroconversion
was assessed using SNT. Incidence density was estimated and compared using multivari-
able Poisson models and hazard of seroconversion was estimated over time.
Principal findings
Initial overall seroprevalence was 34.0% (95%CI: 29.5–38.8%) in cattle and 31.7% (95%CI:
22.9–41.6%) in goats, varying by locality from 18–54%. Seroconversions to RVFV based on
SNT were detected throughout the year, with the incidence rate peaking during the high rain-
fall months of January to March, and differed considerably between years. Overall serocon-
version rate in cattle was 0.59 per animal-year (95% CI: 0.46–0.75) and in goats it was 0.41
per animal-year (95% CI: 0.25–0.64), varying significantly over short distances.
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Conclusions/Significance
The high seroprevalence in all age groups and evidence of year-round viral circulation pro-
vide evidence for a hyperendemic situation in the study area. This is the first study to directly
estimate infection rate of RVFV in livestock in an endemic area in the absence of reported
outbreaks and provides the basis for further investigation of factors affecting viral circulation
and mechanisms for virus survival during interepidemic periods.
Author summary
Rift Valley fever (RVF) is a mosquito-transmitted viral disease that may cause large epi-
demics in domestic livestock and in humans. Although currently largely confined to
Africa, it is of international concern due to its ability to spread and become established in
areas where suitable mosquito vectors occur. Outbreaks occur sporadically, associated
with conditions favourable for proliferation of mosquito populations, such as high rainfall
and flooding, yet their location and timing remain difficult to predict. In other areas there
is evidence that RVF virus is endemic and may circulate without causing outbreaks. How-
ever, the location and extent of such areas is poorly known, as is the transmission dynam-
ics of the virus in those areas. In this paper, we report the existence of such an area of
endemic RVF virus transmission on the tropical coastal plain of South Africa bordering
Mozambique, where we found a high rate of exposure of domestic cattle and goats to the
naturally circulating virus over a two-year period, with no outbreaks being reported.
Research in such areas will help us to assess the potential for spread of the virus to other
areas and also to better understand the behaviour of the virus during periods between
epidemics.
Introduction
Rift Valley fever (RVF) is a zoonotic arboviral disease caused by RVF virus (RVFV), a Phlebo-
virus in the family Phenuiviridae [1], mainly affecting livestock and humans and transmitted
by Aedes and Culex spp. mosquitoes. Non-vector transmission of RVFV is not considered
important in livestock but humans are easily infected by contact with bodily fluids of infected
animals or by inhaling infectious particles [2]. Human infection may present in a self-limiting
febrile disease with signs including fever, severe headache, malaise, muscle pain and nausea,
but in severe cases can result in encephalopathy, haemorrhagic signs, retinopathy and even
death. The disease in ruminants may be characterized by necrotic hepatitis but may also be
inapparent or mild, and in pregnant animals usually results in abortions and neonatal mortali-
ties [2].
The virus was first isolated in Kenya in 1930 [3], and has been endemic in sub-Saharan
Africa ever since. The virus spread beyond sub-Saharan Africa when outbreaks occurred in the
Nile delta in Egypt during 1977–1978 causing mortalities in both humans and livestock [4, 5].
It was first recorded in Mauritania and Senegal in West Africa in 1987 [6] and spread beyond
mainland Africa, to Saudi Arabia and Yemen in 2000 [7–9], the Comoros in 2007 [10] and
Madagascar in 1990 [11]. Three major RVF epidemics have occurred in South Africa, during
1950–1951, 1974–1975 and more recently 2008–2011 [12]. During the 2010 outbreaks a total
of 302 human infections were diagnosed with a case fatality rate of 8% [13] and a loss of 19,000
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head of livestock was reported. Species such as buffaloes, camels and other wildlife were also
affected [14]. These large epidemics have occurred mainly following unusually heavy rains on
the relatively dry central plateau of South Africa. However, in the periods between these large
epidemics, several smaller outbreaks or isolated cases have occurred both in the interior and in
the eastern parts of the country [12].
The fate of the virus during the long interepidemic periods in South Africa is poorly under-
stood. The virus has been isolated from newly emerged, unfed Aedes lineatopennis (Ae. mcin-
toshi) in East Africa, suggesting that it may survive extended periods in aedine mosquito eggs,
which are very resilient in dry conditions [15]. Romoser et al. [16] provided laboratory evi-
dence in support of transovarial transmission in artificially infected Ae. mcintoshi, and it
remains the most popular theory for interepidemic survival of RVFV; however, evidence for
its occurrence in nature is limited. Other possibilities are the occurrence of low-level interepi-
demic circulation of virus between vectors and unknown hosts in endemic areas, or disappear-
ance of virus from an area with later re-introduction from an endemic area via movement of
infected hosts or vectors [2].
One such endemic area may be the low-lying, tropical eastern part of southern Africa,
including Mozambique and small parts of north-eastern South Africa. Very few outbreaks
have been reported in Mozambique, yet there is serological evidence of widespread exposure
to RVFV in livestock [17] and humans [18]. RVFV was responsible for a small outbreak in
goats in the Maputo Province, close to the South African border, in 2014 [19]. Recently, the
overall seroprevalence of RVFV antibodies in seven provinces of Mozambique was reported to
be 37% in cattle, 30% in African buffalo (Syncerus caffer), and 29% in domestic ruminants in
the Maputo Province [20]. In South Africa, RVFV was isolated from Ae. circumluteolus in the
tropical coastal region of far northern KwaZulu-Natal (KZN) in 1955 [21] and at the same
time neutralizing antibodies to RVFV were found in 12% of domestic livestock [22] and 10%
of humans [23]. However, subsequent efforts to detect the virus in mosquitoes in that region
were unsuccessful [24]. There have also not been any reports of clinical cases of RVF in that
region, although further south along the KZN coast there was some evidence of RVFV circula-
tion and sporadic clinical cases in 1972–1973 [25] and in a dairy herd in 1981 [26].
Various reports have inferred the occurrence of interepidemic circulation of RVFV on the
basis of seropositivity in the absence of reported outbreaks or vaccination, in livestock [17, 27,
28] wildlife [29, 30] and humans [31, 32]. Two recent studies have reported longitudinal fol-
low-up of sentinel sheep and goats in Kenya, reporting low rates of seroconversion in areas
that had previously experienced outbreaks [33, 34]. However, no published studies have
attempted to quantify the rate of seroconversion in livestock by follow-up of seronegative ani-
mals in a region where outbreaks have never been reported.
The objectives of this study were to determine whether there was evidence of recent circula-
tion of RVFV in the tropical region of far northern KwaZulu-Natal, South Africa, to estimate
the seroprevalence in cattle and goats, and to estimate the incidence rate and patterns of sero-
conversion in domestic ruminants over a two-year period.
Materials and methods
Ethics statement
The study protocol was approved by the Animal Ethics Committee of the University of Preto-
ria (V013-16) and the Department of Agriculture, Forestry and Fisheries, Republic of South
Africa, and adhered to the specifications of the South African National Standard (SANS
10386–2008): “The Care and Use of Animals for Scientific Purposes”. Support for the project
was obtained from the Director of Veterinary Services of KwaZulu-Natal and the State
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Veterinarian: Jozini. Verbal consent was obtained from animal owners after the aims of the
study were explained to them by the State-employed animal health technicians. Farmers were
rewarded for their participation by providing them with small amounts of animal health prod-
ucts such as wound aerosol, topical treatments and endoparasiticides.
Study area
The study was conducted on the Maputaland coastal plain in far northern KwaZulu-Natal just
south of the Mozambique border, an area with a tropical climate [35] characterised by warm,
dry winters and hot, wet summers (Fig 1). In the Pongolo River floodplain, the core of the
study area, the summer temperatures range from 23–40˚C, winter temperatures range from
16–26˚C and mean annual rainfall is 600–800 mm [36]. The northwards-flowing Pongolo
River forms a floodplain at an elevation of 30–50 m above sea level, approximately 10–15 km
to the east of the foothills of the Lebombo Mountains, which rise to about 650 m above sea
level. The study area contains a mosaic of bushland, thicket, wooded grassland, riverine forest
and floodplain vegetation [37]. Depending on rainfall, seasonal flooding of the Pongolo,
Ingwavuma and Usuthu Rivers inundates about 13,000 ha of floodplain, filling numerous
pans, some of which retain water during the dry season [38]. The construction of the Pongola-
poort Dam in 1973 largely disrupted this cycle, with flooding only occurring with heavy rain-
falls or with periodic opening of sluice gates. In very dry years, permanent water may only be
present in the Pongolo and Usuthu Rivers and in very few of the larger pans. This study started
during a drought period when most of the pans were dry (Fig 2).
Fig 1. A map of the study area showing major rivers and temporary wetlands, with the locations of the nine diptanks
where cattle were sampled and the area where goats were sampled for the cross-sectional study. The map was constructed
for this manuscript in Esri ArcGIS 10.2 using country boundaries from Esri ArcGIS Online, diptank coordinates collected
during the study, and river [39], wetland [40] and protected area boundary [41] data available under a Creative Commons
Attribution (CC BY 4.0) license.
https://doi.org/10.1371/journal.pntd.0007296.g001
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Livestock in the study area (mainly cattle and goats) belong to numerous small-scale farm-
ers and are communally grazed. Animals range widely during the day, during the dry season
foraging mainly in the floodplains, and may be confined in pens at night. Much of the area lies
within a foot-and-mouth disease (FMD) protection zone and cattle are brought weekly (sum-
mer) or every two weeks (winter) to diptanks where they are inspected by animal health tech-
nicians for signs of FMD and plunge-dipped for ectoparasite control using amitraz. For this
inspection purpose, most cattle are individually identified using ear tags. The only vaccinations
applied are those provided by the State, namely brucellosis, anthrax, blackquarter and some-
times lumpy skin disease vaccines.
Study design and sampling
The study took the form of an initial cross-sectional survey of individually identified cattle at
nine diptanks (Fig 1) during June 2016, followed by a longitudinal follow-up of seronegative
cattle to detect and quantify seroconversion. The nine diptanks were selected on the basis of
Fig 2. Actual monthly rainfall recorded at Ndumo Game Reserve (NGR) in the study area, with 30-year average. Totals above the bars indicate rainfall for each year
(July—June). The blue arrow indicates the study period (June 2016—June 2018).
https://doi.org/10.1371/journal.pntd.0007296.g002
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their location adjacent to the floodplain of the Pongolo River and its tributaries (seven dip-
tanks) and the eastern coastal plain (two diptanks), as well as the willingness of farmers and
animal health technicians to participate.
Of the seven diptanks in the western part of the study area, all were situated within 1.5 km
of the Pongolo River, except for Mpala which was adjacent to a small tributary which held water
for almost the entire study period and Ndumo which was about 4 km from the Pongolo River
and adjacent to the Ingwavuma River which remained dry throughout the study period. The
two diptanks in the eastern part of the study area were situated in a very sandy area with a
mosaic of grassland and bush and with numerous small temporary pans during the wet season.
Sample size (n) was calculated in order to detect a seroprevalence (Pexp) of 25% with an
allowable error (d) of 10% and 95% confidence, using the formula n = 1.962 Pexp(1 –Pexp) / d2
[42]. The required sample size of 73 was then multiplied by a design effect (D) of 5.9, calculated
by assuming an intracluster correlation coefficient (ρ) of 0.1 and a cluster size (m) of 50 ani-
mals per diptank, using the formula D = 1 + ρ(m– 1) [43]; the overall required sample size was
therefore 432.
Animals were selected using systematic random sampling, selecting 2–5 animals per farmer
at each diptank as they passed through a crush either before or after dipping. Only cattle >6
months old were sampled. Following serological testing of samples from the cross-sectional
study, as many seronegative animals as possible, as well as a small number of seropositive ani-
mals, were then re-sampled during 13 sampling episodes at 1-2-month intervals between
November 2016 and June 2018. To compensate for loss to follow-up, some additional cattle
from the same owners were recruited at various times during the study.
A smaller study of the same type was conducted in goats in an area close to one of the dip-
tanks (Fig 1); 104 goats belonging to seven farmers were sampled during February to April
2017 and seronegative animals were re-sampled at 1–2 monthly intervals until June 2018.
Blood samples were collected from the jugular vein of goats and coccygeal vein of cattle.
Samples were refrigerated and transported to a BSL2+ laboratory at the Faculty of Veterinary
Science, University of Pretoria, where they were centrifuged. The sera were inactivated at 56˚C
for 1 hour and stored at -20˚C until used.
Serology
All cattle serum samples that were collected for the cross-sectional study were tested for RVFV
IgG antibodies using an IgG sandwich enzyme-linked immunosorbent assay (ELISA) with
reported sensitivity of 96.3% and specificity of 99.7% in cattle [44]. In addition, approximately
every second sample (due to economic constraints) was tested using the serum neutralization
test (SNT). Where possible, samples that tested positive for RVFV IgG were also tested for IgM
antibodies using an IgM capture ELISA with reported sensitivity of 100% in sheep and speci-
ficity of 99.2% in cattle [44]. In order to detect seroconversion, all samples collected during the
longitudinal study, as well as all goat serum samples, were tested using SNT.
Heat-inactivated serum samples were tested by the IgG sandwich ELISA using a previously
described and validated method [44]. F96 Maxisorp Immunoplates (AEC-Amersham) were
coated with anti-RVF hyperimmune mouse ascitic fluid. Optical densities (OD) were mea-
sured at 450 nm. The net OD values were first recorded for each serum as the value deter-
mined with the RVFV antigen minus the value determined with the control antigen and
subsequently converted into percentage of the OD value of a high positive control serum. A
cut-off value optimized for this assay (PP value�30) was used.
The IgM capture ELISA was performed following a method previously described [44].
Briefly: plates were coated overnight at 4˚C with 100 μl rabbit anti-sheep IgM. OD was
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determined at 450 nm. The PP was determined as above and an optimized cut-off value of
PP�30 was used.
The SNT was performed in 96-well plate (AEC-Amersham) format according to the stan-
dard protocol of the Virology Section, Department of Veterinary Tropical Diseases, Faculty of
Veterinary Science, University of Pretoria, which follows the method prescribed by the World
Organisation for Animal Health [45]. Briefly: Sera were diluted 1:5 in PBS+ (phosphate buff-
ered saline with added MgCl and CaCl) and two-fold dilutions of the serum were made. The
TCID50 was determined using the Karber method [46]. A volume of 100 TCID50 virus (Smith-
burn vaccine strain) was added to each dilution and incubated at 37˚C for 60 min. A total of
80 μl of African green monkey kidney cells (Vero) (480,000 cells/mL) in MEM containing 5%
foetal calf serum (Biowest, Celtic) was added to each well. The microplates were incubated at
37˚C in an atmosphere containing 5% CO2 and observed daily for cytopathic effect; the titre
was taken as the dilution at which 50% of the cells were affected. Results were only accepted if
all controls gave the expected results (virus control, positive serum and negative serum). A
serum dilution of�1:10 was used to define seropositivity.
Statistical analysis
For samples tested during the cross-sectional study using both the IgG ELISA and the SNT,
sensitivity and specificity of the IgG ELISA were estimated, with exact binomial 95% confi-
dence intervals, using the SNT as the gold standard. For animals on which both tests were
used, the SNT result was used to define seropositivity, otherwise the IgG ELISA result was
used. The RVFV seroprevalence in cattle in June 2016 was calculated overall and by diptank,
age group (�2 y, 2.5–3.5 y, 4–5.5 y,�6 y) and sex. For goats the seroprevalence in February
2017 was calculated overall and by age group and sex. Exact binomial 95% confidence intervals
were calculated and seroprevalence was compared between diptanks (cattle only), age groups
and sexes using multiple logistic regression to control for confounding.
The occurrence of seroconversion was defined as a seronegative result (either during the
cross-sectional study as defined above, or during subsequent testing by SNT) followed by a
sample from the same animal that tested positive by SNT at a serum dilution of 1:10 or greater.
The incidence rate of seroconversion over the 24-month study period (16 months in goats)
was then calculated by including all animals that were sampled more than once (irrespective of
date of first sampling) and that were seronegative on the first sampling. For the animals that
did not seroconvert, animal-time at risk was calculated as the interval between the first and last
tests. For animals that did seroconvert, the date of seroconversion was unknown, but was
assumed to be the midpoint between the last negative and first positive test. The seroconver-
sion rate was calculated as the number of seroconversions divided by the total animal-years at
risk observed, with Poisson exact 95% confidence limits. Estimates were calculated overall for
each species, separately for each year of the study (June 2016 to June 2017 and July 2017 to
June 2018) and for cattle also separately for each diptank. Associations of age, sex and place
with incidence rate were then assessed by including these variables in a multiple Poisson
regression model, using animal-time at risk as the exposure variable.
For each species, the seroconversion rate with 95% confidence interval was plotted over
time as the derivative of the kernel-smoothed Nelson-Aalen cumulative hazard estimator,
using a 60-day kernel width. For this purpose, instead of the midpoint-imputed seroconver-
sion date used above, a randomly selected date between the last negative and first positive test
was used for seroconverting animals in order to avoid systematic bias in incidence rate estima-
tion over time [47]. All statistical analyses were done using Stata 15 (StataCorp, College Sta-
tion, TX, U.S.A.) and statistical significance was assessed at P<0.05. Risk surfaces for
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seroprevalence and seroconversion rate in the study area were created by interpolation using
ordinary kriging in ArcGIS 10.2 (Esri, Redlands, CA, U.S.A.).
Results
A total of 423 cattle was sampled from nine diptanks in June 2016, of which 131 (31.0%) were
positive by IgG ELISA. Of 241 cattle tested using SNT, 87 (36.1%) were positive; of these, 75
were IgG ELISA-positive, giving an estimated sensitivity for the IgG ELISA of 86.2% (95% CI:
77.1–92.7%). Of 154 SNT-negative animals, 152 were IgG ELISA-negative, giving an estimated
specificity of 98.7% (95% CI: 95.4–99.8%).
Seroprevalence
The seroprevalence in cattle sampled from nine diptanks in June 2016, based on IgG ELISA
and SNT, was 34.0% (144/423; 95% CI 29.5–38.8%). Seroprevalence within diptanks varied
from 18% to 54% and it was high in all age groups (Table 1). The multiple logistic regression
model (S1 Table) showed significant differences between diptanks, with the odds of seroposi-
tivity at Mbangwini (Odds ratio (OR) = 4.5; 95% CI: 1.8–11; P = 0.001), Phelandaba (OR = 4.6;
95% CI: 1.8–12; P = 0.001) and Shemula (OR = 5.8; 95% CI: 2.3–15; P<0.001) being higher
than at Madlakude. Odds of seropositivity was the lowest in the 2–4 y age group, being signifi-
cantly higher in the 4–6 y age group (OR = 2.4; 95% CI: 1.3–4.4; P = 0.006), tending to be
higher in animals >6 y (P = 0.095), and tending to be higher in females than in males
(P = 0.064). Of the 144 seropositive animals, 114 were tested using the IgM ELISA and 5
(4.4%) were positive; this included 2/6 (33%) of samples that were SNT-positive but IgG
ELISA-negative. Therefore the estimated prevalence of IgM-positive animals in the general
population was 1.3% (5/393; 95% CI: 0.4–2.9%).
Table 1. Rift Valley fever seroprevalence in cattle at diptanks in far northern KwaZulu-Natal, June 2016.
Variable n Seroprevalence (%)� 95% CI
Diptank
Madlakude 50 18 7–29
Masondo 21 19 2–36
Mpala 52 25 13–37
Namaneni 50 26 14–38
Ndumo 50 30 17–43
Hlanjwana 50 34 21–47
Phelandaba 50 44 30–58
Mbangwini 50 48 34–62
Shemula 50 54 40–68
Age (years)
<2 56 34 22–46
2 –<4 96 23 15–31
4–6 157 39 31–47
>6 114 34 25–43
Sex
female 331 36 31–41
male 92 27 18–36
Total 423 34.0 29.5–38.0
� Based on IgG ELISA, confirmed by serum neutralization test in 241/423 samples.
https://doi.org/10.1371/journal.pntd.0007296.t001
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The seroprevalence in goats sampled during February—April 2017, determined using SNT,
was 31.7% (33/104; 95% CI: 22.9–41.6%) (Table 2). Although seroprevalence appeared to
increase with age, this was not statistically significant (P = 0.549) in the multiple logistic regres-
sion model (S2 Table), nor was there a significant difference between sexes (P = 0.139). The
overall seroprevalence in cattle and goats varied substantially across the study area (Fig 3),
with foci of high seroprevalence along the Pongolo River, but was not clearly linked to the
presence of wetlands.
Seroconversion rate
Of the 279 cattle that were seronegative in June 2016 by IgG ELISA, or by ELISA and SNT if
both tests were used, 103 were re-sampled between one and eight times during the study
period. An additional 91 SNT-seronegative cattle were recruited at various times during the
study period and re-sampled at least once, therefore 194 initially seronegative animals were
sampled at least twice over periods ranging between 28 and 721 days. Assuming that serocon-
versions occurred, on average, midway between the last negative and first positive test, a total
of 111.8 animal-years at risk were observed. Due to various factors, including logistical reasons
and varying farmer compliance, the majority of animals (167/194) were followed up at four of
the diptanks (Namaneni, Mpala, Shemula and Ndumo), with very few followed up at Hlanj-
wana (13), Madlakude (8) and Masondo (6) and none at Mbangwini and Phelandaba.
Seroconversion, determined by SNT, occurred at some stage during the study period in 66
(34%) of initially seronegative cattle. Seroconversions were observed during every interval
between samplings for the duration of the study, and at every diptank followed except
Masondo, where only six animals were followed for five months each. The overall incidence
rate of seroconversion in cattle between June 2016 and June 2018 was 0.59 seroconversions per
animal-year (95% CI: 0.46–0.75) (Table 3). Seroconversion rate varied between diptanks, with
the lowest rate recorded at Namaneni (0.35 per animal-year) and the highest rates observed at
Hlanjwana (1.50 per animal-year) and Ndumo (1.01 per animal-year) (Fig 4). There was no
clear relationship at diptank level between the initial seroprevalence in 2016 and the subse-
quent rate of seroconversion, and the correlation between the two outcomes was not signifi-
cant (Spearman’s ρ = 0.29; P = 0.535).
There was a marked variation in the estimated rate of seroconversion in cattle over time,
with the rate being lower during the second year of the study (Table 3). Seroconversion rate
increased from October 2016 to peak at just over 1.5 per animal-year between February and
April 2017, dropping to almost zero during August-September 2017 and then showing a lower
peak of just over 0.5 per animal-year during December-January 2018 (Fig 5).
Table 2. Rift Valley fever seroprevalence in goats in far northern KwaZulu-Natal, February-April 2017.
Variable n Seroprevalence (%)� 95% CI
Age (years)
0.5–1.5 25 24 9–45
>1.5–3.5 36 28 14–45
>3.5 43 40 25–56
Sex
female 70 36 25–48
male 28 18 6–37
Total 104 31.7 22.9–41.6
� Based on serum neutralization test.
https://doi.org/10.1371/journal.pntd.0007296.t002
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Fig 3. Rift Valley fever virus seroprevalence in cattle and goats in far northern KwaZulu-Natal determined using IgG
ELISA and serum neutralization test: risk surfaces created by interpolation using ordinary kriging. The map was
constructed for this manuscript in Esri ArcGIS 10.2 using country boundaries from Esri ArcGIS Online, diptank coordinates
collected during the study, and river [39], wetland [40] and protected area boundary [41] data available under a Creative
Commons Attribution (CC BY 4.0) license.
https://doi.org/10.1371/journal.pntd.0007296.g003
Table 3. Incidence rate of seroconversion� to Rift Valley fever virus in cattle and goats in far northern KwaZulu-Natal between June 2016 and June 2018, expressed
as numbers of seroconversions per animal-year.
CATTLE Year 1 (June 2016 –June 2017) Year 2 (July 2017 –June 2018) Total
Animal-years at risk† Incidence rate 95% CI Animal-years at risk† Incidence rate 95% CI Animal-years at risk† Incidence rate 95% CI
Diptank
Mpala 16.87 0.83 0.45–1.39 11.09 0.18 0.02–0.65 27.96 0.57 0.33–0.93
Ndumo 11.17 1.34 0.75–2.21 6.64 0.45 0.09–1.32 17.81 1.01 0.60–1.60
Namaneni 16.44 0.36 0.13–0.79 15.00 0.33 0.11–0.78 31.44 0.35 0.17–0.63
Shemula 13.74 0.73 0.35–1.34 10.64 0.19 0.02–0.68 24.37 0.49 0.25–0.86
Hlanjwana 3.25 1.84 0.68–4.01 0.75 0.00 0.00–4.90 4.01 1.50 0.55–3.26
Madlakude 3.74 0.80 0.17–2.35 0 - - 3.74 0.80 0.17–2.35
Masondo 2.41 0.00 0.00–1.53 0 - - 2.41 0.00 0.00–1.53
Total 67.62 0.80 0.60–1.04 44.13 0.27 0.14–0.47 111.75 0.59 0.46–0.75
GOATS Year 1 (February–June 2017) Year 2 (July 2017 –June 2018) Total
Animal-years at risk† Incidence rate 95% CI Animal-years at risk† Incidence rate 95% CI Animal-years at risk† Incidence rate 95% CI
Total 14.20 0.92 0.49–1.57 34.32 0.20 0.08–0.42 48.52 0.41 0.25–0.64
� Seroconversion defined as a previously seronegative animal becoming seropositive based on the serum neutralization test at a serum dilution of 1:10 or greater.
† Seroconversion assumed to have occurred midway between the last negative and the first positive test.
https://doi.org/10.1371/journal.pntd.0007296.t003
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Fig 4. Rift Valley fever virus seroconversion rate in cattle and goats in far northern KwaZulu-Natal between June 2016
and June 2018, determined by serum neutralization test: Risk surfaces created by interpolation using ordinary kriging.
The map was constructed for this manuscript in Esri ArcGIS 10.2 using country boundaries from Esri ArcGIS Online, diptank
coordinates collected during the study, and river [39], wetland [40] and protected area boundary [41] data available under a
Creative Commons Attribution (CC BY 4.0) license.
https://doi.org/10.1371/journal.pntd.0007296.g004
Fig 5. Seroconversion rate of cattle to Rift Valley fever virus in far northern KwaZulu-Natal between June 2016
and June 2018, determined by serum neutralization test and expressed as numbers of seroconversions per animal-
year, plotted using the derivative of the kernel-smoothed Nelson-Aalen cumulative hazard estimator.
https://doi.org/10.1371/journal.pntd.0007296.g005
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Of the goats that were initially seronegative, 95 were followed up for periods of time ranging
between 28 and 482 days, of which 20 (21%) seroconverted. A total of 48.5 animal-years at risk
were observed. The overall incidence rate of seroconversion in goats between February 2017
and June 2018 was 0.41 seroconversions per animal-year (95% CI: 0.25–0.64) (Table 3) and
was also markedly lower during the second summer of the study (Fig 6). The seroconversion
rate is not shown after December 2017 since no further seroconversions were observed in the
study animals.
For cattle and goats combined, the overall rate of seroconversion was 0.54 per animal-year
(95% CI: 0.43–0.66), and was 0.82 per animal-year (95% CI: 0.63–1.04) during the first year
and 0.24 per animal-year (95% CI: 0.15–0.38) during the second year. The associations of spe-
cies, sex, study year and place with seroconversion rate in the multiple Poisson regression
model are shown in Table 4. The rate did not differ significantly between species and sexes.
However, the rate during the second study year was only a third of that during the first year
(P<0.001), and significant differences were observed between locations, with Ndumo and
Hlanjwana showing higher rates than Namaneni, where the lowest rate was recorded.
Discussion
This study showed evidence of a high level of exposure to RVFV in the study area, demonstrat-
ing active circulation of RVFV in livestock not associated with reported outbreaks, and to our
knowledge is the first published study to quantify directly the seroconversion rate in livestock
using the gold-standard SNT. Previous studies to detect interepidemic circulation have
inferred low-level viral transmission in epidemic-prone areas by ELISA-based detection of IgG
or IgM.
The study was done in an area of South Africa where outbreaks of RVF have never been
reported, although occasional small outbreaks and suspected cases had occurred in the more
temperate inland and coastal areas to the south of the study area between 1972 and 1986 [12,
25, 26]. Elsewhere in Africa, endemic circulation of RVFV is known or suspected to occur in
Fig 6. Seroconversion rate of goats to Rift Valley fever virus in far northern KwaZulu-Natal between February
and December 2017, determined by serum neutralization test and expressed as numbers of seroconversions per
animal-year, plotted using the derivative of the kernel-smoothed Nelson-Aalen cumulative hazard estimator.
https://doi.org/10.1371/journal.pntd.0007296.g006
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many areas. Limited numbers of RVFV infections were confirmed to occur in sheep and cattle
every year during a seven year interepidemic period in Zimbabwe [48]. A seroprevalence of
33% in cattle and 26% in goats was reported during an interepidemic period in outbreak-
prone Garissa County, Kenya during 2013, six years after the last major outbreak [49]. Along
the Nile River in Sudan, where outbreaks also occur, a prevalence of 33% in cattle and 34% in
goats was found [50]. In Mauritania, also in an area that had experienced outbreaks, a sero-
prevalence of 15% was detected in cattle and 4% in small ruminants, and IgM and viral RNA
was detected in one bovine [51]. A series of surveys in Mayotte found seroprevalences of up to
37% in cattle in the absence of reported outbreaks [52]. A seroprevalence of 17% was reported
in Rwanda, also in the absence of reported outbreaks [53]. In Maputo Province, Mozambique,
neighbouring our study area to the north, a survey in 2010–2011, during the large outbreak in
the central interior of South Africa, found a seroprevalence in cattle of 37%, similar to that in
our study [54]. This was followed in 2014 by the detection of a small outbreak of abortion in
goats due to RVFV, less than 100 km north of our study area and in the same ecological zone
[19]. The 1.3% IgM seroprevalence in this study was comparable to that reported in other
endemic areas, e.g. 0.5% in Tanzania [28] and 0–4% in Mayotte [52], indicating the presence
of low numbers of recent infections. The seroprevalence in the current study was therefore
similar to or higher than those reported elsewhere in Africa where interepidemic circulation is
known or suspected to occur and is consistent with ongoing or endemic circulation of RVFV
with low numbers of clinical cases likely occurring but overlooked, misdiagnosed or
unreported.
Seroprevalence was high in all age groups throughout the study area. Numerous studies
have shown that seroprevalence is usually higher in older animals [17, 28, 55, 56], although in
northern Somalia it was higher in younger animals [57]. The high seroprevalence in young
animals can be a result of a recent outbreak; however, it is unlikely that a large, extensive out-
break would have gone unnoticed. In addition, rainfall in the study area during 2014–2016
Table 4. Factors associated with incidence rate of seroconversion to Rift Valley fever virus in cattle and goats in
far northern KwaZulu-Natal between June 2016 and June 2018.
Variable and level Incidence rate ratio 95% CI P-value
Species
Cattle 1� - -
Goats 1.62 0.77–3.41 0.206
Sex
Female 1� -
Male 0.64 0.36–1.14 0.131
Year
2016–2017 1� - -
2017–2018 0.31 0.18–0.53 <0.001
Place
Namanini 1� - -
Mpala 1.48 0.69–3.19 0.318
Ndumo 2.39 1.11–5.13 0.025
Hlanjwana 3.01 1.10–8.21 0.031
Madlakude 1.46 0.40–5.26 0.566
Shemula 1.40 0.62–3.19 0.417
Masondo 0.00 0.00 -1 0.977
� Reference level
https://doi.org/10.1371/journal.pntd.0007296.t004
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had been well below average and the study area, as well as much of South Africa had experi-
enced the worst drought in 23 years [58]. Release of water from the Pongolapoort Dam had
not occurred and most of the floodplain pans were empty. Nevertheless, permanent water was
still present in the major rivers and some pans, providing breeding habitat for the mosquito
vectors. It is therefore likely that the high seroprevalence in all age groups is indicative of a
hyperendemic situation [59] with continuous or sporadic viral activity despite the dry condi-
tions, and including recent viral circulation.
Rate or force of infection is a key parameter in modelling of infectious diseases in an
attempt to understand the factors determining disease transmission. Our study showed a high
seroconversion rate to RVFV in livestock, even during dry conditions, with substantial spatial
and temporal variation. Low levels of seroconversion in sentinel sheep and goats have recently
been reported in Kenya in areas in which outbreaks are known to occur [33, 34]; however, pos-
itive tests were not confirmed using virus neutralization and incidence rates were not reported.
In the Kruger National Park, South Africa, seroconversion was demonstrated in 5/227 African
buffalo (Syncerus caffer), indicating a low annual incidence rate of 1–3% [60]. This was also in
the eastern part of the country, adjacent to Mozambique, but outside the tropical zone and in a
wildlife area with no livestock and a very low human population. The epidemiology of RVFV
in our study area more likely approximates that in other tropical areas of Africa and therefore
our results provide useful insight into the dynamics of RVFV transmission in endemic areas,
both during interepidemic periods in areas where outbreaks are known to occur, and in areas
where outbreaks are not reported. Specifically, the range of seroprevalence and seroconversion
rates observed in our study will inform the design of further epidemiological studies in known
or suspected endemic areas, as well as the modelling of RVFV transmission in such ecosys-
tems. Knowledge of likely force of infection in endemic areas, and its seasonal variation, will
also inform studies to assess the risk of spread of RVFV from such areas via animal
movements.
As expected, the highest infection rate was seen during mid to late summer, when water lev-
els are highest and mosquitoes are most abundant. However, despite the fact that rainfall was
much higher during the second year of the study, the seroconversion rate was markedly lower,
approximately one third of that observed during the first year. It is possible that the drought
over the 1-2-year period prior to the study resulted in lower than normal infection rates with a
resultant increased number of susceptible animals. This would have increased the number of
viraemic animals available to infect mosquitoes, resulting in a higher than usual infection rate
during the first year, followed by fewer viraemic animals during the second year. However, the
suitable breeding habitat for vectors depends not only on local rainfall, but also on water levels
in rivers that are determined by rainfall in their catchment areas. The important mosquito vec-
tor species in the study area, and their host preferences, are currently poorly known, and many
other factors likely determine their population dynamics, most of which are poorly under-
stood. This study showed very little difference in seroprevalence and seroconversion rate
between cattle and goats, suggesting that RVFV is transmitted by one or more mosquito spe-
cies without strict host preferences.
The differences in seroprevalence and in seroconversion rates between locations could not
be readily explained based on geographic location or environmental factors. Two diptanks
with high seroprevalence and seroconversion rates (Mbangwini and Hlanjwana, respectively)
were close together and near the lower (northern) Pongolo River; however, they could not be
distinguished from the other locations close to the river based on environmental or climatic
variables and separate rainfall figures were not available for each location; animal management
practices were also similar for all locations. Therefore, the risk and rate of RVFV infection are
likely determined by a complex interplay of host, vector and environmental factors which our
High RVFV seroconversion rate in livestock in absence of outbreaks
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007296 May 3, 2019 14 / 19
results show may vary substantially within a region, even over small distances. This is consis-
tent with the marked spatial variation in seroprevalence observed in other studies [34, 52, 54,
56]. The lack of an association between seroprevalence (reflecting past seroconversion rate)
and subsequent seroconversion rate in our study, as well as the differences in seroconversion
rates between the first and second years of the study, also indicates that these factors vary sub-
stantially over time. More detailed, fine-scale eco-epidemiological studies to describe the
dynamics of these virus-vector-host-environment interactions are required in order to better
understand the behaviour of and risk posed by RVFV in such endemic ecosystems.
The seroprevalence in livestock found in this study was much higher than the 12% observed
in 1955, the only previous study done in this region [22]. Since then the human and livestock
populations in the area have increased tremendously, resulting in a substantial increase in
RVFV host density, and it is possible that this has changed the dynamics of viral circulation.
Nevertheless, the absence of sheep, the most susceptible livestock species, and the extensive
farming system with year-round breeding may be responsible for the fact that large outbreaks
do not occur in the area. However, sporadic cases of abortion and neonatal mortality are
unlikely to be reported and investigated and may be ascribed to other causes; in addition, dis-
ease surveillance in the area is sub-optimal and access to veterinary services is difficult. There-
fore, the contribution of RVF to livestock morbidity in the area is unknown and requires
further investigation.
Likewise, the potential impact of RVF on human health in the area is unknown. It is gener-
ally considered that human infection by RVFV in southern Africa occurs mainly via contact
with infected animal tissues from clinical cases and that infection from mosquito bites is less
common, as most human cases have a history of exposure to infected animal tissues and the
known mosquito vectors tend to be zoophilic [2]. Therefore, the lack of reported cases in live-
stock in our study area suggest that human exposure to the virus may be low. However, the last
published serological surveys done in this region were in the 1950’s, in which 16% of human
sera (19/118) collected from locations within in our present study area were protective against
RVFV [23]. To our knowledge there has never been a report of clinical RVF in humans in the
area; however, the fact that malaria is common there may result in other causes of febrile ill-
ness being overlooked. In support of this hypothesis, a recent study in Maputo, 100 km north
of our study area, found a 10% RVFV IgG seroprevalence in febrile patients at a primary health
care facility, with seroconversion to RVFV in 5%, concluding that undiagnosed RVFV infec-
tions occur in that region and that most RVF cases are misdiagnosed as malaria [61]. There-
fore, the current status and potential impact of RVFV infection in humans in our study area,
and in similar areas along the coastal plain of southern Africa, urgently require further
investigation.
Conclusion
The results of this study show the presence of RVFV antibodies and active seroconversion in
domestic ruminants in far northern KwaZulu-Natal, indicating that RVFV is circulating in the
area at a rate that varies by location, season and year. Further investigation should be done
into the important mosquito vectors in the area, the factors affecting viral circulation and sur-
vival, and the impact of the presence of RVFV on animal and human health.
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